title: Osteonecrosis of the jaws in intravenous bisphosphonate use: Proposal for a modification of the clinical classification.
authors: Jose V
authors: JV
authors: Bagan
authors: Yolanda
authors: Y
authors: Jimenez
authors: Jose M
authors: JM
authors: Diaz
authors: Judith
authors: J
authors: Murillo
authors: Jose M
authors: JM
authors: Sanchis
authors: Rafael
authors: R
authors: Poveda
authors: Enrique
authors: E
authors: Carbonell
authors: Carmen
authors: C
authors: Gavalda
authors: Crispian
authors: C
authors: Scully
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D007275:Injections, Intravenous; D007571:Jaw Diseases / Q000139:chemically induced / Q000145:classification / Q000628:therapy*; D010020:Osteonecrosis / Q000139:chemically induced / Q000145:classification / Q000628:therapy*; D017410:Practice Guidelines as Topic
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates